Education
About Us
Working with TipRanks
Follow Us
APONTIS PHARMA AG (DE:APPH)
XETRA:APPH
See the Price Targets and Ratings of:
APPH Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Warburg Research
€10
Sell
-11.11%
Downside
Reiterated
11/19/24
APONTIS PHARMA AG (APPH) Receives a Sell from Warburg Research
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Warburg Research
€10
Sell
-11.11%
Downside
Reiterated
11/19/24
APONTIS PHARMA AG (APPH) Receives a Sell from Warburg Research
Best Analysts Covering APONTIS PHARMA AG
Which Analyst Should I Follow If I Want to Buy DE:APPH and Sell After:
1 Month
xxx
Success Rate
5/12 ratings generated profit
Average Return
+3.02%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 41.67% of your transactions generating a profit, with an average return of +3.02% per trade.
3 Months
xxx
Success Rate
5/12 ratings generated profit
Average Return
+4.67%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 41.67% of your transactions generating a profit, with an average return of +4.67% per trade.
1 Year
Success Rate
6/12 ratings generated profit
Average Return
+17.29%
reiterated a sell rating 5 months ago
Copying Christian Ehmann's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +17.29% per trade.
2 Years
xxx
Success Rate
6/12 ratings generated profit
Average Return
+26.45%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +26.45% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
APPH Analyst Recommendation Trends
Rating
Nov 23
Jan 24
Feb 24
Apr 24
Nov 24
Strong Buy
4
3
3
3
2
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
4
3
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
APPH Stock Forecast FAQ
What is DE:APPH’s average 12-month price target, according to analysts?
Based on analyst ratings, APONTIS PHARMA AG’s 12-month average price target is 10.00.
What is DE:APPH’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:APPH, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is APONTIS PHARMA AG a Buy, Sell or Hold?
APONTIS PHARMA AG has a consensus rating of Moderate Sell, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is APONTIS PHARMA AG’s share price target?
The average share price target for APONTIS PHARMA AG is 10.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €10.00 ,and the lowest forecast is €10.00. The average share price target represents -11.11% Decrease from the current price of €11.25.
The highest analyst share price target is €10.00 ,and the lowest forecast is €10.00. The average share price target represents -11.11% Decrease from the current price of €11.25.
What do analysts say about APONTIS PHARMA AG?
APONTIS PHARMA AG’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of APONTIS PHARMA AG?
To buy shares of DE:APPH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.